Pulmonx (LUNG) EBT Growth (3y) (2022 - 2025)
Pulmonx (LUNG) EBT Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 17.92% |
| 10 | Pulmonx | 94.15 Mn | 24.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.81% |
| Jun 30, 2025 | -0.90% |
| Mar 31, 2025 | 3.16% |
| Dec 31, 2024 | -0.73% |
| Sep 30, 2024 | -11.24% |
| Jun 30, 2024 | -5.77% |
| Mar 31, 2024 | -2.91% |
| Dec 31, 2023 | -13.72% |
| Sep 30, 2023 | -57.33% |
| Jun 30, 2023 | -10.64% |
| Mar 31, 2023 | -30.53% |
| Dec 31, 2022 | -45.88% |
| Sep 30, 2022 | -49.45% |